Cas:304889-93-8 2-(2-oxochromen-7-yl)oxypropanoic acid manufacturer & supplier

Chemical Name:2-(2-oxochromen-7-yl)oxypropanoic acid

CAS.NO:304889-93-8

Synonyms:2-[(2-oxo-2H-chromen-7-yl)oxy]propanoic acid;MFCD01462958;2-(2-Oxo-2h-Chromen-7-Yloxy)-PropionicAcid

Molecular Formula:C₁₂H₁₀O₅

Molecular Weight:234.20500

HS Code:2932209090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:454.8ºC at 760 mmHg

Density:1.384g/cm3

Index of Refraction:1.592

PSA:76.74000

Exact Mass:234.05300

LogP:1.64490

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-[(2-oxo-2H-chromen-7-yl)oxy]propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-Oxo-2h-Chromen-7-Yloxy)-PropionicAcid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(2-oxo-2H-chromen-7-yl)oxy]propanoic acid Use and application,MFCD01462958 technical grade,usp/ep/jp grade.

Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. 2-(2-oxochromen-7-yl)oxypropanoic acid manufacturer API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 2-(2-oxochromen-7-yl)oxypropanoic acid supplier The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 2-(2-oxochromen-7-yl)oxypropanoic acid vendor API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 2-(2-oxochromen-7-yl)oxypropanoic acid factory The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively).